Jove
Visualize
Contact Us

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetics in Sarcoidosis and Its Burden as a Multisystem Disease.

Seminars in respiratory and critical care medicine·2025
Same author

Sarcoidosis: a state-of-the-art review.

The European respiratory journal·2025
Same author

Sarcoidosis in the Genomic Era: From Genetic Drivers to Tailored Therapies.

Current allergy and asthma reports·2025
Same author

From genes to granulomas: the genetic blueprint of sarcoidosis.

Current opinion in immunology·2025
Same author

Unraveling Genetics in Sarcoidosis: Next Steps.

Archivos de bronconeumologia·2025
Same author

WASOG 2023 conference highlights.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2024
Same journal

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Current opinion in pulmonary medicine·2026
Same journal

Oxygen therapy in interstitial lung disease - navigating benefit and burden.

Current opinion in pulmonary medicine·2026
Same journal

Preclinical and clinical advances in pulmonary hypertension associated with systemic sclerosis.

Current opinion in pulmonary medicine·2026
Same journal

Advancing lung transplantation: current challenges and future directions.

Current opinion in pulmonary medicine·2026
Same journal

Association between upper airway obstruction and pulmonary hypertension in children with Down syndrome.

Current opinion in pulmonary medicine·2026
Same journal

Molecular mechanisms of environmental risk factors for interstitial lung disease.

Current opinion in pulmonary medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 22, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

416

Big data in sarcoidosis.

Natalia V Rivera1

  • 1Division of Respiratory Medicine, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Current Opinion in Pulmonary Medicine
|July 5, 2024
PubMed
Summary
This summary is machine-generated.

Advancements in sarcoidosis research rely on collaborative networks and detailed phenotyping. Integrating molecular data is key to understanding this complex disease and developing personalized medicine for better patient outcomes.

More Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.9K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

166

Related Experiment Videos

Last Updated: Jun 22, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

416
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.9K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

166

Area of Science:

  • Immunology
  • Genetics
  • Personalized Medicine

Background:

  • Sarcoidosis is a complex multisystem inflammatory disease of unknown etiology.
  • The disease presents with highly heterogeneous clinical manifestations and variable progression.
  • Understanding sarcoidosis heterogeneity is crucial for effective treatment strategies.

Purpose of the Study:

  • To review recent advancements in sarcoidosis research.
  • To emphasize the role of collaborative networks and phenotype characterization.
  • To highlight the integration of molecular data for personalized medicine.

Main Methods:

  • Review of current literature on sarcoidosis research.
  • Analysis of collaborative network initiatives and biobanking efforts.
  • Integration of findings from molecular and genetic studies.

Main Results:

  • Sarcoidosis exhibits significant clinical heterogeneity.
  • Endophenotyping efforts are advancing the characterization of sarcoidosis subtypes.
  • Technological progress enables large-scale molecular data generation.
  • Collaborative networks and biobanks are facilitating biomarker discovery and therapeutic development.

Conclusions:

  • Collaborative networks, comprehensive phenotyping, and advanced molecular studies are essential for sarcoidosis research.
  • Integrating multilevel molecular data and leveraging biobanks will improve understanding of disease heterogeneity.
  • These approaches are critical for developing personalized medicine strategies and improving patient outcomes in sarcoidosis.